Disclaimer

These materials are intended to be used as examples only of documents to help you implement a school-based vaccination initiative in your school district.

Please note: These materials must be customized to reflect your individual initiative and to ensure compliance with any legal/policy requirements applicable to your initiative.

These materials are not intended to be a substitute for or an influence upon the independent, clinical judgment of the healthcare professional overseeing your vaccination initiative.

Proceed Cancel

FluMist® Frequently Asked Questions

Below you will find materials that can be customized to help you implement
your school-located vaccination clinic (SLVC).

Q: What is FluMist?

FluMist is a flu vaccine given as a gentle nasal mist that is sprayed in each nostril to help prevent the flu. FluMist is for intranasal administration only.1

Q: How effective is FluMist?

In a study of kids 2 years to 5 years of age, FluMist cut the risk of getting the flu in half compared to the shot.1-3

In a study of adults 18 years to 49 years of age, FluMist reduced influenza illness compared to placebo1, 4

Q: Is FluMist a live virus vaccine?

Yes. Like other routine childhood vaccines, such as those for chicken pox or rotavirus, FluMist is a vaccine that contains weakened live viruses to help the body build immunity—but not cause disease.1

Q: Who may be eligible for FluMist?

FluMist is a vaccine approved for the prevention of certain types of influenza disease in children, adolescents, and adults 2-49 years of age. FluMist may not protect everyone who gets it.1

Q: Who may not be able to get FluMist?

FluMist is not right for everyone. FluMist must not be given to: people with history of hypersensitivity to eggs, egg proteins, gentamicin, gelatin or arginine; people with life-threatening reactions to previous influenza vaccinations; and children and adolescents receiving aspirin or aspirin-containing therapy.

Children less than 24 months of age are not eligible for FluMist.

The following people may not be able to get FluMist or may be able to get it only in certain situations: people with asthma or active wheezing, or children less than 5 years of age with recurrent wheezing; people with a history of Guillain-Barré syndrome; people with a weakened immune system; people with long-term medical conditions including heart disease, kidney disease, and metabolic diseases, such as diabetes; and pregnant women.

If you or your child fall into one of these groups, be sure to tell your healthcare provider. They will decide if FluMist is right for you or your child.

Q: What are the most common side effects of FluMist?

Most common side effects include runny nose or nasal congestion, sore throat, and fever. For a full list of side effects, please see section 6.1 in the product information.

Q: How early in the year can someone receive FluMist?

Flu vaccines, including FluMist, can be given as early as the vaccine is available each year.5

Q: Will I get sick from FluMist?

No. The viruses contained in FluMist are weakened and designed not to cause disease.6

Q: If I sneeze after receiving FluMist, will I give the flu to someone else?

No. The live influenza vaccine viruses in FluMist rarely spread from person to person. Even if they do, it is unlikely they will cause illness.6

Q: Can I receive FluMist if I am in close contact with someone with a weakened immune system (e.g., chemotherapy patients)?

Yes. According to the Centers for Disease Control (CDC), people in contact with someone with a weakened immune system—including those receiving chemotherapy—may receive FluMist.5,6

Q: Who can administer FluMist?

Only healthcare workers can administer FluMist.
Healthcare workers at high risk for influenza complications may administer FluMist. These include persons with underlying medical conditions placing them at high risk or who are likely to be at risk, including pregnant women, persons with asthma, and persons ≥50 years of age. However, severely immuncompromised persons should not administer FluMist.5

Q: Is FluMist available through Vaccines for Children (VFC)?

Yes. FluMist is available through the VFC program for eligible patients.



Important Safety and Eligibility Information

Who may be eligible for FluMist®?

FluMist is a vaccine approved for the prevention of certain types of influenza disease in children, adolescents and adults 2-49 years of age. FluMist may not protect everyone who gets it. FluMist is for intranasal administration only.


Who may not be able to get FluMist?

FluMist is not right for everyone. FluMist must not be given to: people with history of hypersensitivity to eggs, egg proteins, gentamicin, gelatin or arginine; people with life-threatening reactions to previous influenza vaccinations; and children and adolescents receiving aspirin or aspirin-containing therapy.


Children less than 24 months of age are not eligible for FluMist.


The following people may not be able to get FluMist or may be able to get it only in certain situations: people with asthma or active wheezing, or children less than 5 years of age with recurrent wheezing; people with a history of Guillain-Barré syndrome; people with a weakened immune system; people with long-term medical conditions including heart disease, kidney disease, and metabolic diseases, such as diabetes; and pregnant women.


If you or your child fall into one of these groups, be sure to tell your healthcare provider. They will decide if FluMist is right for you or your child.


What are the most common side effects of FluMist?

Most common side effects included runny nose or nasal congestion, sore throat, and fever. For a full list of side effects, please see section 6.1 in the following product information.


Please see accompanying complete product information, including information for patients, or visit www.FluMist.com.


References

1. FluMist [package insert]. Gaithersburg, MD: MedImmune, LLC. 2. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356:685-696. 3. Belshe RB, Ambrose CS, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Vaccine. 2008;26(suppl 4):D10-D16. 4. Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;281:137-144. 5. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR. 2009;58(RR-8):1-52. 6. Centers for Disease Control and Prevention. Influenza (flu) Q&A: the nasal-spray flu vaccine (live attenuated influenza vaccine [LAIV]). http://www.cdc.gov/flu/about/qa/nasalspray.html. Accessed April 13, 2010.